Jun 05, 2008 7:30am EDT Rigel to Present at the Needham Biotechnology and Medical Technology Conference
Jun 03, 2008 6:00am EDT Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL
Jun 02, 2008 5:10pm EDT Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
Mar 13, 2008 7:30am EDT Rigel Announces Participation in Upcoming Investor and Partnering Conferences
